SUBSCRIBE
SUBSCRIBE
News   Drug Development

Experimental Pfizer Inc. Drug May Help Rare Bone Cancer

December 28, 2009 | 
1 min read
Bookmark and Share

Reuters -- An early study of Pfizer's experimental drug figitumumab has found it could help fight a rare bone cancer called Ewing's sarcoma, researchers said on Thursday.
Clinical research Phase I
Pfizer
MORE ON THIS TOPIC
Image picture pin up collage poster of falling man guy from destroyed arrow rise up bankrupt concept.
Cancer
Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data
January 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Roche Makes Obesity Splash, Moderna Cans Vaccine Trials, Sarepta’s New Data, More
January 28, 2026
 · 
1 min read
 · 
Heather McKenzie
Businessman holding briefcase walking on graphic stair, start up business concepts.
GLP-1
Roche’s 22% Weight Loss Benefit Seals GLP-1’s Phase III Plans, Boosts Zealand Combo
January 27, 2026
 · 
2 min read
 · 
Annalee Armstrong
Biotechnology and molecular genetic engineering. 3D illustration of science and molecular technology.
Duchenne muscular dystrophy
Sarepta’s DMD Gene Therapy Staves Off Disease Three Years After Treatment
January 26, 2026
 · 
2 min read
 · 
Dan Samorodnitsky